The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Sourcing · Vendor reports · continued

One lot is one lot: when a report becomes a pattern — the long version posts 91–120

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

OO
orbitrap_olaTL3Mass spectrometrist17 Mar 2025#91

Where you submitted more than one vial from a consignment, say so. Intra-consignment comparison is one of the more useful things an individual can contribute.

7 likes 16mo
IA
i.almeidaTL217 Mar 2025#92

Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are different. Both matter for different reasons.

18 likes 16mo
PW
PharmNotes_WhitfieldTL4Pharmacist17 Mar 2025#93
n.rahimi, post #49: The maintainers will ask for missing fields rather than rejecting a report. Filling them in afterwards is normal and nobody minds. Go to post

Seconded. It reads as careful rather than confident, which is the right register.

0 likes in reply to #49 16mo
NB
n.brobergTL217 Mar 2025#94

Where I part company with post #90, and it is a narrow parting.

Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two results that disagree might just be measurement variation.

Marking that as an opinion rather than a finding.

0 likes 16mo
CL
customs_ledgerTL3Regular17 Mar 2025 · edited#95

Narrowing post #92, because the general version has more than one answer.

Comparing your result to somebody else's on a different lot is not a comparison of suppliers. Lot is the unit and it should be in every report.

I would want the raw data before agreeing with my own summary of it.

12 likes 16mo
FW
f.weissTL218 Mar 2025#96

Include the sample handling: how it was stored, how it travelled to the laboratory, how long it sat. A result on badly handled material is measuring the handling.

25 likes 16mo
DS
dr_seongTL3Physician18 Mar 2025#97
baseline_drift, post #41: Where I part company with post #37, and it is a narrow parting. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are different. Both matter for different reasons. I have kept the units in throughout, for the obvious reason. Go to post

The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide.

0 likes in reply to #41 16mo
RF
ro.friskTL218 Mar 2025#98

Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.

The confident version of this sentence would be wrong, so here is the hedged one.

1 like 16mo
NN
n.nybergTL218 Mar 2025 · edited#99

Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are different. Both matter for different reasons.

I am reporting what happened, not recommending it.

2 likes 16mo
ML
m.lehtinenTL218 Mar 2025#100
baseline_drift, post #41: Where I part company with post #37, and it is a narrow parting. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are different. Both matter for different reasons. I have kept the units in throughout, for the obvious reason. Go to post

Saving this. It is the version I will quote when the question comes round again.

8 likes in reply to #41 16mo
SS
s.solbergTL218 Mar 2025#101

Narrowing post #98, because the general version has more than one answer.

Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.

1 like 16mo
HK
h.koodziejTL2Member18 Mar 2025#102

Everything in post #101 holds. The case it does not cover is the one I have.

Report the certificate figure alongside the independent one. The comparison is the point and it is the part most often omitted.

8 likes 16mo
HF
h.fonsecaTL218 Mar 2025 · edited#103
LJankowiak, post #56: Date the submission as well as the result. Turnaround is part of what people want to know and it disappears if only one date is recorded. The short version is the first sentence; the rest is why. Go to post

One lot is one lot. It becomes a pattern at three or four, and the record is built to show which of those you are looking at.

I have seen it go both ways, which is why I hedge.

25 likes in reply to #56 16mo
VK
v.klausenTL3Regular18 Mar 2025#104

Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that reason.

Anyone with a larger sample, please post it.

0 likes 16mo
PF
p.friskTL218 Mar 2025#105

Fair, and the limits you put on it are the part I will remember.

4 likes 16mo
ID
integrator_draftTL3Regular18 Mar 2025#106

I read post #104 twice before replying, because I had assumed the opposite.

Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.

12 likes 16mo
FP
f.petrovTL218 Mar 2025#107
two_year_line, post #47: Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are different. Both matter for different reasons. It is one reading of the data and not the only reasonable one. Go to post

The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide.

One case, stated as one case.

0 likes in reply to #47 16mo
VM
v.milanoviTL3Regular18 Mar 2025#108
i.almeida, post #71: Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. Go to post

Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.

Stating my assumptions rather than smuggling them in.

0 likes in reply to #71 16mo
JC
j.castellanosTL218 Mar 2025 · edited#109

Recording a reorder result against the original is one of the highest-value contributions here, because consistency over time is what a single result cannot show.

Worth saying I have only my own numbers here, and n is small.

0 likes 16mo
CR
c.ramosTL218 Mar 2025#110

A difference inside method repeatability is not a disagreement. Saying so in your own report prevents somebody else reading it as one.

I keep a log of this specifically because memory is unreliable about it.

2 likes 16mo
AF
a.finnegan_rdTL2Dietitian18 Mar 2025#111

Everything in post #107 holds. The case it does not cover is the one I have.

Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are different. Both matter for different reasons.

0 likes 16mo
VK
v.kirchnerTL218 Mar 2025#112

Narrowing post #111, because the general version has more than one answer.

Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.

Worth reading the earlier posts in this thread before acting on mine.

33 likes 16mo
CL
coldchain_liuTL3Regular18 Mar 2025#113
n.moreau, post #59: Comparing your result to somebody else's on a different lot is not a comparison of suppliers. Lot is the unit and it should be in every report. Go to post

Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable.

A single observation, in a thread that deserves better than single observations.

12 likes in reply to #59 16mo
MN
m.nascimentoTL218 Mar 2025#114
j.habermann, post #34: Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. Go to post

Where you have no independent result, a documentation report is still worth filing: what the certificate contained, what it omitted, and how fast a request was answered.

4 likes in reply to #34 16mo
LE
logbook_erinTL3Regular18 Mar 2025#115

Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are different. Both matter for different reasons.

0 likes 16mo
PO
p.ostergaardTL218 Mar 2025#116

I will take the caveat as seriously as the claim, which is the point of putting it there.

25 likes 16mo
CO
c.okaforTL3Regular18 Mar 2025#117

Where you submitted more than one vial from a consignment, say so. Intra-consignment comparison is one of the more useful things an individual can contribute.

The reasoning is more useful than the number, which is why I have shown it.

7 likes 16mo
SG
s.girardTL218 Mar 2025#118
m.restrepo, post #23: Good question, well framed, and I would like to see it answered properly. Go to post

Date the submission as well as the result. Turnaround is part of what people want to know and it disappears if only one date is recorded.

I would call that likely rather than established.

1 like in reply to #23 16mo
DF
d.fontaineTL218 Mar 2025#119

The maintainers will ask for missing fields rather than rejecting a report. Filling them in afterwards is normal and nobody minds.

I checked the source rather than the summary, and they differ.

3 likes 16mo
KS
k.salinasTL218 Mar 2025#120

Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current state of the same supplier's stock.

That is the honest state of it as of this week.

0 likes 16mo